Hospitalisation and mortality trends in ANCA-associated vasculitis in Mexico: results from a nationwide retrospective registry analysis.

ABSTRACT:

Objective

Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) entails substantial morbidity and mortality, yet no epidemiologic evidence exists on its outcomes in Mexico. This study assessed national hospitalisations (2005-2022) and mortality (2000-2022) related to AAV using data from the General Board of Health Information.

Design

Retrospective, population-based time-trend analysis on administrative health data.

Setting

Mexico's national hospital discharge and mortality registries, covering 1 January 2000 through 31 December 2022.

Participants

All individuals aged ≥ 15 years with a primary or secondary International Classification of Diseases, 10th revision, diagnosis of AAV recorded during hospitalisation or on death certificates nationwid

SUBMITTER: Etchegaray-Morales I 

PROVIDER: S-EPMC12481380 | biostudies-literature | 2025 Sep

REPOSITORIES: biostudies-literature